Article Details

AzurRx BioPharma, Inc. (AZRX) EPS Estimated At $-0.18; Sprint (S) Covered By 4 Bulls

Retrieved on: 2018-05-11 17:22:30

Tags for this article:

Click the tags to see associated articles and topics

AzurRx BioPharma, Inc. (AZRX) EPS Estimated At $-0.18; Sprint (S) Covered By 4 Bulls. View article details on hiswai:

Excerpt

<div><b>SOFTBANK GROUP</b> CORP had bought 1.01M shares worth $5.58 million. AzurRx BioPharma, Inc., a clinical development stage biopharmaceutical ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up